BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14677936)

  • 1. Ligand specificity modulated by prolyl imide bond Cis/Trans isomerization in the Itk SH2 domain: a quantitative NMR study.
    Breheny PJ; Laederach A; Fulton DB; Andreotti AH
    J Am Chem Soc; 2003 Dec; 125(51):15706-7. PubMed ID: 14677936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular details of Itk activation by prolyl isomerization and phospholigand binding: the NMR structure of the Itk SH2 domain bound to a phosphopeptide.
    Pletneva EV; Sundd M; Fulton DB; Andreotti AH
    J Mol Biol; 2006 Mar; 357(2):550-61. PubMed ID: 16436281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of a proline-driven conformational switch within the Itk SH2 domain.
    Mallis RJ; Brazin KN; Fulton DB; Andreotti AH
    Nat Struct Biol; 2002 Dec; 9(12):900-5. PubMed ID: 12402030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proline isomerization preorganizes the Itk SH2 domain for binding to the Itk SH3 domain.
    Severin A; Joseph RE; Boyken S; Fulton DB; Andreotti AH
    J Mol Biol; 2009 Apr; 387(3):726-43. PubMed ID: 19361414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific intermolecular association between the regulatory domains of a Tec family kinase.
    Brazin KN; Fulton DB; Andreotti AH
    J Mol Biol; 2000 Sep; 302(3):607-23. PubMed ID: 10986122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the interleukin-2 tyrosine kinase Src homology 2 domain; comparison between X-ray and NMR-derived structures.
    Joseph RE; Ginder ND; Hoy JA; Nix JC; Fulton DB; Honzatko RB; Andreotti AH
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Feb; 68(Pt 2):145-53. PubMed ID: 22297986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory intramolecular association in a tyrosine kinase of the Tec family.
    Andreotti AH; Bunnell SC; Feng S; Berg LJ; Schreiber SL
    Nature; 1997 Jan; 385(6611):93-7. PubMed ID: 8985255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase.
    Lin X; Wang Y; Ahmadibeni Y; Parang K; Sun G
    J Mol Biol; 2006 Apr; 357(4):1263-73. PubMed ID: 16483606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification, crystallization and preliminary crystallographic analysis of the SH2 domain of IL-2-inducible T-cell kinase.
    Joseph RE; Ginder ND; Hoy JA; Nix JC; Honzatko RB; Andreotti AH
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Feb; 67(Pt 2):269-73. PubMed ID: 21301103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heteronuclear NMR studies of the combined Src homology domains 2 and 3 of pp60 c-Src: effects of phosphopeptide binding.
    Tessari M; Gentile LN; Taylor SJ; Shalloway DI; Nicholson LK; Vuister GW
    Biochemistry; 1997 Nov; 36(47):14561-71. PubMed ID: 9398174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the Brk SH3 domain in substrate recognition.
    Qiu H; Miller WT
    Oncogene; 2004 Mar; 23(12):2216-23. PubMed ID: 14676834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
    Kristensen SM; Siegal G; Sankar A; Driscoll PC
    J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A.
    Brazin KN; Mallis RJ; Fulton DB; Andreotti AH
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1899-904. PubMed ID: 11830645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
    Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
    J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.